Linde Nippon Sanso Signs Lucrative Contract With Solar Cell Producer

Linde Nippon Sanso (LNS), a company of The Linde Group, has signed an exclusive contract with Malibu GmbH & Co. KG in Bielefeld, Germany, to supply all of the gases needed to make photovoltaic modules.

The long term contract comprises over-the-fence supply of nitrogen (N2), hydrogen (H2), silane (SiH4), nitrogen trifluoride (NF3), argon (Ar), and helium (He). The turnkey installation includes a complete gas distribution network and gas leak detection system. LNS will also provide on-site gas and chemical management services.

Additionally, Linde and Malibu have entered into a Joint Development Programme for the development of advanced gas technology to improve cell efficiency, throughput and yield. Malibu is a joint venture between energy service provider E.ON and Schüco, a major worldwide provider of building envelope systems.

"This contract shall prove to be strategically invaluable for Linde's fast growing Photovoltaic business", said Dr. Aldo Belloni, member of the Executive Board of Linde AG. "The joint development programme will allow us to further develop our gas technology and to contribute to reducing the cost per watt in solar cell production", added Andreas Günther, president of Linde Nippon Sanso.

Using the innovative thin-film technology, Malibu will initially construct a 40 megawatt (MW) photovoltaic module production line in Osterweddingen, Germany, incorporating multi-layer cell technology for increased efficiency. As the plant is scheduled to increase in size, Linde will add N2, H2 and fluorine (F2) on-site plants.

Posted March 21st,2008

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.